ArticleOncology letters2018

Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway.

Wenjie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.